Co-delivery of axitinib and PD-L1 siRNA for the synergism of vascular normalization and immune checkpoint inhibition to boost anticancer immunity.

On the contrary, heat maps show that gene expression levels of immune-related signaling pathways in Axi/siRNA PD−L1 @NGR-Lipo group displayed an elevated trend, including adaptive immune response (Fig. 10 E), innate immune response (Fig.

also in 145 other papers